The interplay between sex and serious bacterial infections, including bacteremia and sepsis, is complex and more research is ...

Lilly plans to submit orforglipron for approval in weight management by the end of 2025, with a T2D application to follow in ...

Viral hepatitis was the most common cause of infectious disease mortality worldwide after tuberculosis in 2024, according to ...

The World Health Organization (WHO) has released an update on polio following the March 2025 meeting of the International ...

The Sabin Vaccine Institute has begun a trial to evaluate its Marburg vaccine, with the first doses being given to subjects ...

The EMA has approved Cullinan Therapeutics’ clinical trial application for CLN-978, a drug intended to treat rheumatoid ...

More than just a tool for advancing pipelines, trial efficiency is the name of the game when it comes to synthetic control ...